Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism

European Journal of Endocrinology

Volumn 164, Issue 3, 2011, Pages 421-427

  Vezzoli, Giuseppe ^a   Scillitani, Alfredo ^b   Corbetta, Sabrina ^c   Terranegra, Annalisa ^c   Dogliotti, Elena ^c   Guarnieri, Vito ^b   Arcidiacono, Teresa ^a   Paloschi, Vera ^a   Rainone, Francesco ^a   Eller Vainicher, Cristina ^c   Borghi, Loris ^d   Nouvenne, Antonio ^d   Guerra, Angela ^d   Meschi, Tiziana ^d   Allegri, Franca ^d   Cusi, Daniele ^c   Spada, Anna ^c   Cole, David E C ^e   Hendy, Geoffrey N ^f   Spotti, Donatella ^a   Soldati, Laura ^c   more..

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE; CALCIUM; CREATININE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STONE FORMATION; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CREATININE BLOOD LEVEL; GENE LINKAGE DISEQUILIBRIUM; GENE REGULATORY NETWORK; PARATHYROID HORMONE BLOOD LEVEL; RISK FACTOR; GENETICS; GENOTYPE;

ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY CALCULI; LINKAGE DISEQUILIBRIUM; MALE; NEPHROLITHIASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCIUM-SENSING; RISK FACTORS;

EID: 79951971029     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0915     Document Type: Article

References (26)

1. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hedlger MA, Lytton J & Hebert SC. Cloning and characterization of an extracellular Ca-sensing receptor from bovine parathyroid. Nature 1993 366 575-580. (doi:10.1038/366575a0)
2. Canaff L & Hendy GN. Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1β. Journal of Biological Chemistry 2002 277 30337-30350. (doi:10.1074/jbc.M201804200)
3. Canaff L, Zhou X & Hendy GN. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp173. Journal of Biological Chemistry 2008 283 13586-13600. (doi:10.1074/jbc.M708087200)
4. Canaff L & Hendy GN. Human calcium sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. Journal of Biological Chemistry 2005 280 14177-14188. (doi:10.1074/jbc.M408587200)
5. Silverberg SJ & Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nature Clinical Practice. Endocrinology and Metabolism 2006 2 494-503. (doi:10.1038/ncpendmet0265)
6. Farnebo F, Enberg U, Grimelius L, Backdahl M, Schalling M, Larsson C & Farnebo L. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1997 82 3481-3486. (doi:10.1210/jc.82.10. 3481)
7. Corbetta S, Mantovani G, Lania A, Borgato S, Vicentini L, Beretta E, Faglia G, Di Blasio AM & Spada A. Calcium-sensing receptor expression and signaling in human parathyroid adenomas and primary hyperplasia. Clinical Endocrinology 2000 52 339-348. (doi:10.1046/j.1365-2265.2000.00933.x)
8. Kifor O, Moore FD Jr, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC & Brown EM. Reduced immunostaining for the extracellular Ca21-sensing receptor in primary and uremic secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 1598-1606. (doi:10.1210/jc.81.4. 1598)
9. Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK & Pak CYC. Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urological Research 2007 35 123-128. (doi:10.1007/s00240-007-0096-2)
10. Corbetta S, Eller-Vainicher C, Filopanti M, Saeli P, Vezzoli G, Arcidiacono T, Loli P, Syren ML, Soldati L, Beck-Peccoz P & Spada A. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. European Journal of Endocrinology 2006 155 687-692. (doi:10.1530/eje.1.02286)
11. Scillitani A, Guarnieri V, Battista C, De Geronimo S, Muscarella LA, Chiodini I, Cignarelli M, Minisola S, Bertoldo F, Francucci CM, Malavolta N, Piovesan A, Mascia ML, Muscarella S, Hendy GN, D'Agruma L & Cole DEC. Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. Journal of Clinical Endocrinology and Metabolism 2006 92 277-283. (doi:10.1210/jc.2006-0857)
12. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G & Brandi ML. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. Journal of the American Society of Nephrology 2002 13 2517-2523. (doi:10.1097/01.ASN.0000030077.72157.D2)
13. Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren M, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G & Soldati L. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney International 2007 71 1155-1162. (doi:10.1038/sj.ki.5002156)
14. Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E & Soldati L. Calcium kidney stones are associated with a haplotype of the regulatory region of the calcium-sensing receptor gene regulatory region. Nephrology, Dialysis, Transplantation 2010 25 2245-2252. (doi:10.1093/ndt/ gfp760)
15. Scheet P & Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. American Journal of Human Genetics 2006 78 629-644. (doi:10.1086/502802)
16. Barrett JC, Fry B, Maller J & Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 263-265. (doi:10.1093/bioinformatics/bth457)
17. Gordon D, Finch SJ, Nothnagel M & Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Human Heredity 2002 54 22-33. (doi:10.1159/000066696)
18. Ba J, Brown D & Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. American Journal of Physiology. Renal Physiology 2004 285 F1233-F1243. (doi:10.1152/ajprenal.00249. 2003)
19. Renkema KY, Velic A, Dijkman HB, Verkaart S, van der Kemp AW, Nowik M, Timmermans K, Doucet A, Wagner CA, Bindels RJ & Hoenderop JG. The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. Journal of the American Society of Nephrology 2009 20 1705-1713. (doi:10.1681/ASN.2008111195)
20. Bustamante M, Hasler U, Leroy V, deSeigneux S, Dimitrov M, Mordasini D, Rousselot M, Martin PY & Ferraille E. Calciumsensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism. Journal of the American Society of Nephrology 2008 19 109-116. (doi:10.1681/ASN. 2007010092)
21. Motoyama HI & Friedman PA. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. American Journal of Physiology. Renal Physiology 2002 283 F399-F406. (doi:10.1152/ ajprenal.00346.2001)
22. Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL & Bilezikian JP. Nephrolithiasis and bone involvement in primary hyperparathyroidism. American Journal of Medicine 1990 89 327-334. (doi:10.1016/0002-9343(90)90346-F)
23. Evan AE, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC & Worcester BM. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney International 2008 74 223-229. (doi:10.1038/ki.2008.161)
24. Alam M, Kirton JP, Wilkinson FL, Towers E, Sinha S, Rouhi M, Vizard TN, Sage AP, Martin D, Ward DT, Alexander MY, Riccardi D & Canfield AE. Calcification is associated with loss of functional calcium sensing receptor in vascular smooth muscle cells. Cardiovascular Research 2009 81 2660-2668. (doi:10.1093/cvr/cvn279)
25. Kawata T, Nagano N, Obi M, Miyata S, Koyama C, Kobayashi N, Wakita S & Wada M. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney International 2008 74 1270-1277. (doi:10.1038/ki.2008.407)
26. Terranegra A, Ferraretto A, Dogliotti E, Scarpellini M, Corbetta S, Barbieri AM, Spada A, Arcidiacono T, Rainone F, Aloia A, Cusi D, Vezzoli G & Soldati L. Calcimimetic R-568 effects on activity of R990G polymorphism of calcium-sensing receptor. Journal of Molecular Endocrinology 2010 45 245-256. (doi:10.1677JME-10-0034)